Table 1 Numbers of participants in each group throughout the study.
From: Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial)
Start | Females | Males | Half study | Females | Males | End | Females | Males | |
|---|---|---|---|---|---|---|---|---|---|
G1 | 28 | 13 | 15 | 25 | 11 | 14 | 23 | 10 | 13 |
G2 | 13 | 7 | 6 | 13 | 7 | 6 | 11 | 5 | 6 |
41 | 20 | 21 | 38 | 18 | 20 | 34 | 15 | 19 |
